Antagen Biosciences Inc.
Canton, MA Doing business as Antagen
- UEI
- HXD6EFH2ND57
- CAGE
- 59GJ1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 780 Dedham St #800, Canton, MA 02021, USA
- Website
- antagenpharm.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Award to antagen pharmaceuticals | National Institute of Allergy and Infectious Diseases | $300,000 | |
| The goal of the proposed project is to further develop antagen's novel protein nanoparticle-based expression and… | National Institute of Allergy and Infectious Diseases | $299,998 | |
| Sbir topic 081: adjuvant development for vaccines against infectious or immune-mediated diseases | National Institute of Allergy and Infectious Diseases | $600,000 | |
| The objective of this contract is to use immunogens (envs) combined with effective multivalent antigenic display on… | National Institute of Allergy and Infectious Diseases | $599,914 | |
| The purpose of this contract is to evaluate and modulate the molecular pathways involved in regulating and enhancing HIV… | National Institute of Allergy and Infectious Diseases | $599,997 |
About Antagen Biosciences Inc.
Antagen Biosciences Inc., doing business as Antagen Pharmaceuticals, is a for-profit biotechnology company focused on developing biologics to address unmet medical needs in infectious diseases, cancer, and autoimmune diseases. Through federal contract awards, Antagen provides research and development services related to novel vaccines, adjuvants, drug delivery systems, and other biomedical countermeasures.
Specific federal contracts awarded to Antagen include a $300,000 Phase I SBIR award from the National Institute of Allergy and Infectious Diseases to develop an engineered HIV envelope glycoprotein fused to Antagen's FcRider platform, intended to induce broadly neutralizing antibodies against HIV. Antagen also received a $600,000 SBIR award from NIAID to develop novel adjuvants to enhance vaccine efficacy against infectious and immune-mediated diseases. Additional prior awards include $299,998 under the SBIR program to further develop Antagen's nanoparticle-based vaccine delivery platform for inducing durable antibody responses, and $599,914 to use multivalent HIV envelope immunogens delivered on nanoparticles to promote somatic hypermutation toward broadly neutralizing HIV antibodies. All of Antagen's federal awards have been set aside for total small business participation.
SBA capabilities narrative
Platform for biotechnology transformation; biologics manufacturing, biologics supplies; high-throughput drug screening; protein expression system.
Quick answers
What is Antagen Biosciences Inc.'s UEI?
Antagen Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is HXD6EFH2ND57.
What is Antagen Biosciences Inc.'s CAGE code?
Antagen Biosciences Inc.'s CAGE code is 59GJ1.
What is Antagen Biosciences Inc.'s primary NAICS code?
Antagen Biosciences Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Antagen Biosciences Inc. located?
Antagen Biosciences Inc.'s physical address in SAM.gov is 780 Dedham St #800, Canton, MA 02021, USA.
Is Antagen Biosciences Inc. registered in SAM.gov?
Yes. Antagen Biosciences Inc.'s SAM.gov registration is active through February 8, 2027.
What is Antagen Biosciences Inc.'s most recent federal award?
Antagen Biosciences Inc.'s most recent federal contract award is Award to antagen pharmaceuticals (75N93022C00020), from National Institute of Allergy and Infectious Diseases, on July 5, 2022.
On GovTribe
See Antagen Biosciences Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors